Neglected Parasitic Infections and Poverty in the United States

PLoS Neglected Tropical Diseases

Volumn 8, Issue 9, 2014, Pages

  Hotez, Peter J ^a,b,c,d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c RICE UNIVERSITY   (United States)

^d BAYLOR UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; CORTICOSTEROID; METRONIDAZOLE; SUBSTANCE P; TINIDAZOLE;

ARTICLE; ASTHMA; BIPOLAR DISORDER; CHAGAS DISEASE; COGNITIVE DEFECT; CYSTICERCOSIS; DISEASE TRANSMISSION; EPILEPSY; HEADACHE; HELMINTHIASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCEPHALUS; LUNG FUNCTION; NEGLECTED DISEASE; NEUROCYSTICERCOSIS; PARASITOSIS; PELVIC INFLAMMATORY DISEASE; POVERTY; PREMATURE LABOR; PREVALENCE; RISK FACTOR; SCHIZOPHRENIA; SEIZURE; TAENIA SOLIUM; TOXOCARA CANIS; TOXOCARA CATI; TOXOCARIASIS; TOXOPLASMA GONDII; TOXOPLASMOSIS; TRICHOMONIASIS; TRYPANOSOMA CRUZI; UNITED STATES; VAGINITIS; VISUAL IMPAIRMENT;

EID: 84907584695     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003012     Document Type: Article

References (56)

1. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, et al. (2007) Control of neglected tropical diseases. N Engl J Med 357: 1018–1027.
2. World Health Organization (2010) Working to overcome the global impact of neglected tropical diseases: First WHO report on neglected tropical diseases. Geneva: World Health Organization. Available: http://www.who.int/neglected_diseases/2010report/en/. Accessed 2 August 2013.
3. Hotez PJ, (2013) NTDs V.2.0: “Blue Marble Health”—Neglected Tropical Disease Control and Elimination in a Shifting Health Policy Landscape. PLoS Negl Trop Dis 7: e2570.
4. Hotez PJ, (2008) Neglected infections of poverty in the United States of America. PLoS Negl Trop Dis 2: e256.
5. Denavas-Walt C, Proctor BD, Smith JC, US Census Bureau (2011) Income, Poverty, and Health Insurance Coverage in the United States: 2010. Available: http://www.census.gov/prod/2011pubs/p60-239.pdf. Accessed 25 August 2012.
6. Shaefer HL, Edin K (2013) Rising extreme poverty in the United States and the response of federal means-tested transfer programs. National Poverty Center Working Paper Series #13-06, May 2013. Available: http://npc.umich.edu/publications/u/2013-06-npc-working-paper.pdf. Accessed 28 March 2014.
7. US Census Bureau (2012) Poverty: Income, Poverty and Health Insurance in the United States: 2011—Tables & Figures. Available: http://www.census.gov/hhes/www/poverty/data/incpovhlth/2011/tables.html. Accessed 6 April 2013.
8. Gabe T (2013) Poverty in the United States: 2012. Congressional Research Service, Report for Congress, November 13, 2013. Available: http://www.fas.org/sgp/crs/misc/RL33069.pdf. Accessed 6 April 2013.
9. Hotez PJ, Fenwick A, Savioli L, Molyneux DH, (2009) Rescuing the bottom billion through control of neglected tropical diseases. Lancet 373: 1570–1575.
10. Hotez P, Stillwaggon E, McDonald M, Todman L, DiGrazia L, (2010) National summit on neglected infections of poverty in the United States. Emerg Infect Dis 16: e1.
11. Sunlight Foundation, OpenCongress (2011) H.R. 528 – Neglected Infections of Impoverished Americans Act of 2011. Available: https://www.opencongress.org/bill/112-h528/show. Accessed 6 April 2013.
12. Pew Research Center (2014) Hispanic Trends Project. Statistical Portrait of the Hispanic Population in the United States, 2001. Hispanic Population, by State: 2011. Available: http://www.pewhispanic.org/files/2013/02/Statistical-Portrait-of-Hispanics-in-the-United-States-2011_FINAL.pdf. Accessed 2 August 2013.
13. Hotez PJ, Wilkins PP, (2009) Toxocariasis: America's most common neglected infection of poverty and a helminthiasis of global importance. PLoS Negl Trop Dis 3: e400.
14. Won KY, Kruszon-Moran D, Schantz PM, Jones JL, (2008) National seroprevalence and risk factors for zoonotic Toxocara spp. Infection. Am J Trop Med Hyg 79: 552–557.
15. Congdon P, Lloyd P, (2011) Toxocara infection in the United States: the relevance of poverty, geography and demography as risk factors, and implications for estimating county prevalence. Int J Publ Health 56: 15–24.
16. Jones JL, Kruszon-Moran D, Won K, Wilson M, Schantz PM, (2008) Toxoplasma gondii and Toxocara spp. Co-infection. Am J Trop Med Hyg 78: 35–39.
17. Walsh MG, (2011) Toxocara infections and diminished lung function in a nationally representative sample from the United States population. Int J Parasitol 41: 243–247.
18. Walsh MG, Haseeb MA, (2012) Reduced cognitive function in children with toxocariasis in a nationally representative sample of the United States. Int J Parasitol 42: 1159–1163.
19. Quattrocchi G, Nicoletti A, Marin B, Bruno E, Druet-Cabanac M, Preux P-M, (2012) Toxocariasis and epilepsy: systematic review and meta-analysis. PLoS Negl Trop Dis 6: e1775.
20. Pinelli E, Aranzamendi C, (2012) Toxocara infection and its association with allergic manifestations. Endocrin Metabol Immun Disorders Drug Targets 12: 33–44.
21. Woodhall D, Starr MC, Montgomery SP, Jones JL, Lum F, et al. (2012) Ocular toxocariasis: epidemiologic, anatomic, and therapeutic variations based on a survey of ophthalmic subspecialists. Ophthalmology 119: 1211–1217.
22. Othman AA, (2012) Therapeutic battle against larval toxocariasis: are we still far behind? Acta Trop 124: 171–178.
23. Starr MC, Montgomery SP, (2011) Soil-transmitted helminthiases in the United States: a systematic review – 1940–2010. Am J Trop Med Hyg 85: 680–684.
24. Serpa JA, Graviss EA, Kass JS, White AC, Jr (2011) Neurocysticercosis in Houston, Texas. Medicine 90: 81–86.
25. Croker C, Redelings M, Reporter R, Sorvillo F, Mascola L, et al. (2012) The impact of neurocysticercosis in California: a review of hospitalized cases. PLoS Negl Trop Dis 6: e1480.
26. Baird RA, Wiebe S, Zunt JR, Halperin JJ, Gonseth G, et al. (2013) Evidence-based guideline: treatment of parenchymal neurocysticercosis. Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 80: 1424–1429.
27. Robinson P, Garza A, Weinstock J, Serpa JA, Goodman JC, et al. (2012) Substance P causes seizures in neurocysticercosis. PLoS Pathog 8: e1002489.
28. Sorvillo F, Wilkins P, Shafir S, Eberhard M, (2011) Public health implications of cysticercosis acquired in the United States. Emerg Infect Dis 17: 1–6.
29. Bern C, Montgomery SP, (2009) An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 49: e52–e54.
30. Bern C, Kjos S, Yabsley MJ, Montgomery SP, (2011) Trypanosoma cruzi and Chagas' disease in the United States. Clin Microbiol Rev 24: 655–681.
31. Lee BY, Bacon KM, Bottazzi ME, Hotez PJ, (2013) Global economic burden of Chagas disease: a computational simulation model. Lancet Infect Dis 13: 342–348.
32. Buekens P, Almendares O, Carlier Y, Dumonteil E, Eberhard M, et al. (2008) Mother-to-child transmission of Chagas disease in North America: why don't we do more? Matern Child Health J 12: 283–286.
33. Centers for Disease Control and Prevention (2012) Congenital transmission of Chagas disease – Virginia, 2010. MMWR Morb Mortal Wkly Rep 61: 477–479.
34. Kapelusznik L, Varela D, Montgomery SP, Shah AN, Steurer FJ, et al. (2013) Chagas disease in Latin American immigrants with dilated cardiomyopathy in New York City. Clin Infect Dis 57: e7.
35. Sarkar S, Strutz SE, Frank DM, Rivaldi C-L, Sissel B, et al. (2010) Chagas disease risk in Texas. PLoS Negl Trop Dis 4: e836.
36. Cantey PT, Stramer SL, Townsend RL, Kamel H, Ofafa K, et al. (2012) The United Trypanosoma cruzi infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion 52: 1922–1930.
37. Stimpert KK, Montgomery SP, (2010) Physician awareness of Chagas disease, USA. Emerg Infect Dis 16: 871–872.
38. Verani JR, Montgomery SP, Schulkin J, Anderson B, Jones JL, (2010) Survey of obstetrician-gynecologists in the United States about Chagas disease. Am J Trop Med Hyg 83: 891–895.
39. Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M, (2007) Toxoplasma gondii infection in the United States, 1999–2004, decline from the prior decade. Am J Trop Med Hyg 77: 405–410.
40. Jones JL, Holland GN, (2010) Short report: annual burden of ocular toxoplasmosis in the United States. Am J trop Med Hyg 82: 464–465.
41. Lopez A, Dietz V, Wilson M, Navin TR, Jones JL, (2000) Preventing congenital toxoplasmosis. MMWR Recomm Rep 49: 37–75.
42. Boyer K, Hill D, Mui E, Wroblewski K, Karrison T, Dubey JP, et al. (2011) Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin Infect Dis 53: 1081–1089.
43. Olariu TR, Remington JS, McLeod R, Alam A, Montoya JG, (2011) Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants. Pediatr Infect Dis J 30: 1056–1061.
44. Jones JL, Krueger A, Schulkin J, Schantz PM, (2010) Toxoplasmosis in prevention and testing in pregnancy, survey of obstetrician-gynaecologists. Zoonoses Publ Health 57: 27–33.
45. Torrey EF, Bartko JJ, Yolken RH, (2012) Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull 38: 642–647.
46. Arling TA, Yolken RH, Lapidus M, Langenberg P, Dickerson FB, et al. (2009) Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J Nerv Ment Dis 197: 905–908.
47. Hamdani N, Daban-Huard C, Lajnef M, Richard JR, Delavest M, et al. (2013) Relationship between Toxoplasma gondii infectiona nd bipolar disorder in a French sample. J Affect Disord 148: 444–448.
48. Coleman JS, Gaydos CA, Witter F, (2013) Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: new concepts and controversies. Obstet Gynecol Surv 68: 43–50.
49. Kissinger P, Amedee A, Clark RA, Dumestre J, Theall KP, et al. (2009) Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis 36: 11–16.
50. Quinlivan EB, Patel SN, Grodensky CA, Golin CE, Tien HC, et al. (2012) Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care. Sex Transm Dis 39: 671–677.
51. Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, et al. (2007) The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001–2004. Clin Infect Dis 45: 1319–1326.
52. Kirkcaldy RD, Augostini P, Asbel LE, Bernstein KT, Kerani RP, et al. (2012) Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009–2010. Emerg Infect Dis 18: 939–943.
53. Yoder JS, Wallace RM, Collier SA, Beach MJ, Hlavasa MC, (2012) Cryptosporidiosis surveillance – United States, 2009–2010. MMWR Surveill Summ 61: 1–12.
54. Yoder JS, Gargano JW, Wallace RM, Beach MJ, (2012) Giardiasis surveillance - United States, 2009–2010. MMWR Surveill Summ 61: 13–23.
55. Hall RL, Jones JL, Hurd S, Smith G, Mahon BE, et al. (2012) Population-based active surveillance for Cyclospora infection – United States, Foodborne Diseases Active Surveillance Network (FoodNet), 1997–2009. Clin Infect Dis 54 Suppl 5: S411–S417.
56. Kessler DA, Shi PA, Avecilla ST, Shaz BH, (2013) Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center. Transfusion 53: 1083–1087.